SCHEMBL5780678

SCHEMBL5780678

CCc1nc2c(C)cc(C)nc2n1Cc1cccc(CO)c1-c1cccc(CO[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5780702 0.93 AGTR1 (0.45) —
SCHEMBL5426654 0.80 AGTR1 (0.48) —
SCHEMBL5417453 0.80 — —
SCHEMBL5420494 0.76 — —
SCHEMBL5422429 0.76 AGTR1 (0.48) —
SCHEMBL5425898 0.72 GPR4 (0.57) —
SCHEMBL5430154 0.69 — —
SCHEMBL14409680 0.68 — —
SCHEMBL4340113 0.67 GPR4 (0.57) —
SCHEMBL4340114 0.67 GPR4 (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724271-A1 PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUTROPHILIC INFLAMMATION DISEASE KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-11-22 — — EP disclosed
Send feedback